<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方 | wechat-feeds</title><link>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</link><description>世事洞明皆学问，人情练达即文章</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 11 Jun 2021 10:10:46 +0800</pubDate><image><url>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</url><title>医药魔方 | wechat-feeds</title><link>http://MzA4MDA4MTIzMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>先声药业Kevin Oliver：中国药企BD应有全球视野，高度关注肿瘤、CNS和自免领域进展</title><link>https://mp.weixin.qq.com/s/W59f5PYESN0mqh7QxDolsg</link><description></description><content:encoded><![CDATA[先声药业Kevin Oliver：中国药企BD应有全球视野，高度关注肿瘤、CNS和自免领域进展]]></content:encoded><pubDate>Fri, 11 Jun 2021 07:44:24 +0800</pubDate></item><item><title>绿叶制药抗抑郁症1类新药盐酸安舒法辛缓释片上市申请获CDE受理</title><link>https://mp.weixin.qq.com/s/vbdrtkmJjJCc9t8a4dRLGA</link><description></description><content:encoded><![CDATA[绿叶制药抗抑郁症1类新药盐酸安舒法辛缓释片上市申请获CDE受理]]></content:encoded><pubDate>Fri, 11 Jun 2021 07:44:24 +0800</pubDate></item><item><title>溶瘤病毒药物全球研发概览</title><link>https://mp.weixin.qq.com/s/-x-cbSwF02KB6xg3899jIQ</link><description></description><content:encoded><![CDATA[溶瘤病毒药物全球研发概览]]></content:encoded><pubDate>Fri, 11 Jun 2021 07:44:24 +0800</pubDate></item><item><title>朗煜医药1类新药Cavosonstat治疗中重度哮喘中美II期临床试验启动</title><link>https://mp.weixin.qq.com/s/LAFL32bjCH7zyo1g4Uat5g</link><description></description><content:encoded><![CDATA[朗煜医药1类新药Cavosonstat治疗中重度哮喘中美II期临床试验启动]]></content:encoded><pubDate>Fri, 11 Jun 2021 07:44:24 +0800</pubDate></item><item><title>倒计时8天！中国生物医药五大榜单即将揭晓</title><link>https://mp.weixin.qq.com/s/lcB65LwK7tqdfWtzqpi4EA</link><description></description><content:encoded><![CDATA[倒计时8天！中国生物医药五大榜单即将揭晓]]></content:encoded><pubDate>Fri, 11 Jun 2021 07:44:24 +0800</pubDate></item><item><title>里程碑！首个国产ADC药物获批！胃癌之外还有重大突破值得期待</title><link>https://mp.weixin.qq.com/s/zCwKQGmUXEquOSc4lTl9fw</link><description></description><content:encoded><![CDATA[里程碑！首个国产ADC药物获批！胃癌之外还有重大突破值得期待]]></content:encoded><pubDate>Thu, 10 Jun 2021 07:49:58 +0800</pubDate></item><item><title>全国药品带量采购进入“大合并”竞争时代！</title><link>https://mp.weixin.qq.com/s/kAZJoEkBvNHVPLH-YM43VA</link><description></description><content:encoded><![CDATA[全国药品带量采购进入“大合并”竞争时代！]]></content:encoded><pubDate>Thu, 10 Jun 2021 07:49:58 +0800</pubDate></item><item><title>免费通道！在BioChina，遇见创新者！</title><link>https://mp.weixin.qq.com/s/eOm4Q-R927kbarsocC24Fg</link><description></description><content:encoded><![CDATA[免费通道！在BioChina，遇见创新者！]]></content:encoded><pubDate>Thu, 10 Jun 2021 07:49:58 +0800</pubDate></item><item><title>BioBAY核酸药物研发论坛</title><link>https://mp.weixin.qq.com/s/SjX_wspFezi04iVkJXp_Hg</link><description></description><content:encoded><![CDATA[BioBAY核酸药物研发论坛]]></content:encoded><pubDate>Thu, 10 Jun 2021 07:49:58 +0800</pubDate></item><item><title>欧加隆重出江湖，能否再次打响女性健康领域的百年品牌？</title><link>https://mp.weixin.qq.com/s/LimcmoyewL0M-Up-B_v4jA</link><description></description><content:encoded><![CDATA[欧加隆重出江湖，能否再次打响女性健康领域的百年品牌？]]></content:encoded><pubDate>Wed, 09 Jun 2021 07:25:01 +0800</pubDate></item><item><title>国内首个！乐普生物TF ADC提交中国新药临床申请</title><link>https://mp.weixin.qq.com/s/XN9lJdqPFMRByb0VW-W5RA</link><description></description><content:encoded><![CDATA[国内首个！乐普生物TF ADC提交中国新药临床申请]]></content:encoded><pubDate>Wed, 09 Jun 2021 07:25:01 +0800</pubDate></item><item><title>恒瑞医药64项研究入选ASCO年会，卡瑞利珠单抗力撑“半壁江山”</title><link>https://mp.weixin.qq.com/s/IPfiAA-Q2C-UjOaJIWZN5Q</link><description></description><content:encoded><![CDATA[恒瑞医药64项研究入选ASCO年会，卡瑞利珠单抗力撑“半壁江山”]]></content:encoded><pubDate>Wed, 09 Jun 2021 07:25:01 +0800</pubDate></item><item><title>德琪医药合作伙伴公布Eltanexor治疗去甲基化药物难治的骨髓增生异常综合征的最新临床数据</title><link>https://mp.weixin.qq.com/s/KgsRkK-OwGJ3_CcoLlnGaw</link><description></description><content:encoded><![CDATA[德琪医药合作伙伴公布Eltanexor治疗去甲基化药物难治的骨髓增生异常综合征的最新临床数据]]></content:encoded><pubDate>Wed, 09 Jun 2021 07:25:01 +0800</pubDate></item><item><title>倒计时10天！BioChina大会即将开幕</title><link>https://mp.weixin.qq.com/s/4yDgVKKPDeUpA1T-SJ__Hw</link><description></description><content:encoded><![CDATA[倒计时10天！BioChina大会即将开幕]]></content:encoded><pubDate>Wed, 09 Jun 2021 07:25:01 +0800</pubDate></item><item><title>诺华first in class口服 IgA 肾病新药II 期研究达到主要终点</title><link>https://mp.weixin.qq.com/s/cdujqbAQLFtRLrS_hUH4Sg</link><description></description><content:encoded><![CDATA[诺华first in class口服 IgA 肾病新药II 期研究达到主要终点]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item><item><title>FDA批准Biogen阿尔茨海默症新药aducanumab</title><link>https://mp.weixin.qq.com/s/SIrF-hpVpH_1oIDXr8QxCw</link><description></description><content:encoded><![CDATA[FDA批准Biogen阿尔茨海默症新药aducanumab]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item><item><title>EGFR T790M一线疗法对比：阿美替尼 vs 奥希替尼</title><link>https://mp.weixin.qq.com/s/GM8CJDqLItAOJG7E_L-unw</link><description></description><content:encoded><![CDATA[EGFR T790M一线疗法对比：阿美替尼 vs 奥希替尼]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item><item><title>晚期食管癌一线治疗：前有虎狼，后有追兵</title><link>https://mp.weixin.qq.com/s/sPe9jNtbquMWzNusYLrpDw</link><description></description><content:encoded><![CDATA[晚期食管癌一线治疗：前有虎狼，后有追兵]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item><item><title>亚盛医药Bcl-2抑制剂治疗R/R CLL/SLL最新数据公布：ORR达80%</title><link>https://mp.weixin.qq.com/s/NLaLM_GJKBPe69NRM57-_g</link><description></description><content:encoded><![CDATA[亚盛医药Bcl-2抑制剂治疗R/R CLL/SLL最新数据公布：ORR达80%]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item><item><title>紧随前局长！FDA“2号”加盟谷歌子公司</title><link>https://mp.weixin.qq.com/s/Zsiszsvb1v4FFUvQT5hIwg</link><description></description><content:encoded><![CDATA[紧随前局长！FDA“2号”加盟谷歌子公司]]></content:encoded><pubDate>Tue, 08 Jun 2021 07:56:51 +0800</pubDate></item></channel></rss>